February 27, 2024



Pfizer STOPS distribution of its anti-smoking drug Chantix after finding cancer-causing carcinogens in the popular prescription

Daily Mail.com

Pfizer is pausing distribution of its anti-smoking treatment, Chantix, after finding elevated levels of cancer-causing agents called nitrosamines in the pills.

The drug maker is recalling 12 lots of the anti-smoking drug.  

Pfizer said the impacted lots of Chantix contained levels of nitrosamines, but insisted there is ‘no immediate risk to patients taking this medication’ and the recall is out of an abundance of caution.

Read more…